Ultrasound assessment of postplacental copper intrauterine device position 6 months after placement during cesarean delivery.
Copper intrauterine device
Intrauterine device complication
Intrauterine device expulsion
Postpartum contraception
Postpartum intrauterine device
Postplacental intrauterine device
Journal
Contraception: X
ISSN: 2590-1516
Titre abrégé: Contracept X
Pays: United States
ID NLM: 101767748
Informations de publication
Date de publication:
2020
2020
Historique:
received:
06
04
2020
revised:
14
09
2020
accepted:
16
09
2020
entrez:
16
11
2020
pubmed:
17
11
2020
medline:
17
11
2020
Statut:
epublish
Résumé
The objective was to describe the sonographic position of copper intrauterine devices (IUDs) 6 months after insertion during cesarean delivery. This prospective, observational study followed participants who received a copper IUD during cesarean delivery. We performed pelvic examination at 6 weeks and 6 months and sonography at 6 months to determine IUD position. Patients had additional examinations as needed to address complications. Sixty-nine participants provided outcomes through 6 months: 41 (59%) had correctly positioned IUDs, 21 (30%) had malpositioned intrauterine IUDs, 5 experienced expulsion (3 partial, 2 complete), and 2 had elective removal; 52 (75%) had missing strings. Missing strings at 6 weeks predicted an incorrect IUD position in 22 of 52 participants (positive predictive value 42%), and visible or palpable strings predicted a correct IUD position in 7 of 12 participants (negative predictive value 58%). Although 59% of copper IUDs placed during cesarean were correctly positioned at 6 months, nearly one third were malpositioned. Ultrasound may be indicated for patients receiving a copper IUD during cesarean delivery as checking IUD strings alone does not assure correct placement. Providers offering postpartum IUDs should ensure that appropriate processes for the evaluation and management of devices with missing strings or abnormal position are available to all patients regardless of insurance status.
Identifiants
pubmed: 33196037
doi: 10.1016/j.conx.2020.100040
pii: S2590-1516(20)30023-X
pmc: PMC7644571
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100040Subventions
Organisme : NICHD NIH HHS
ID : K12 HD001265
Pays : United States
Informations de copyright
© 2020 The Author(s).
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Contraception. 2012 Aug;86(2):102-5
pubmed: 22264666
Obstet Gynecol. 2015 Jul;126(1):5-11
pubmed: 26241250
Contraception. 2011 Sep;84(3):240-3
pubmed: 21843687
Contraception. 2015 Mar;91(3):198-203
pubmed: 25499587
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Obstet Gynecol. 2018 Oct;132(4):895-905
pubmed: 30204688
Contraception. 2018 Mar;97(3):215-218
pubmed: 29128372
Am J Obstet Gynecol. 2018 Aug;219(2):183.e1-183.e9
pubmed: 29870737
Obstet Gynecol. 2010 Nov;116(5):1079-87
pubmed: 20966692
Contraception. 2019 Aug;100(2):101-105
pubmed: 31108053